|
|
|
Lawrence Baizer, Ph.D.
Scientific Review Officer
Neurogenesis and Cell Fate (NCF)
Molecular, Cellular and Developmental Neuroscience (MDCN)
Division of Neuroscience, Development and Aging
|
| |
NIH/CSR
Center for Scientific Review, Room 4190
6701 Rockledge Dr. Bethesda, MD 20892 |
| |
|
Email: baizerl@csr.nih.gov |
Phone Number: 301-435-1257
|
|
Dr. Lawrence Baizer earned his Ph.D. in pharmacology from the University of Colorado Health Sciences Center, where his dissertation research involved the role of cyclic nucleotides in the regulation of neurotransmitter release. After postdoctoral work in molecular neurobiology at Massachusetts General Hospital/Harvard Medical School, Dr. Baizer moved to the Neurological Sciences Institute of the Oregon Health Sciences University, where he was a principal investigator from 1989-2000. His laboratory investigated the molecular mechanisms of action of Growth-Associated Protein-(GAP)-43, a protein involved in axonal growth during development and regeneration. From 2000-2003 Dr. Baizer was employed as a senior scientist at Bioject, Incorporated, where he explored new applications for the company's technology and was involved in several clinical vaccine trials. |
Last Update 11/25/2009
[Organizational
Chart]
Any content changes, comments or suggestions should be provided to the
CSR IT Directory@mail.nih.gov
|